Correction to: BMC Med 13, 237 (2015)

https://doi.org/10.1186/s12916-015-0495-0

There was missing information in the Competing Interests section of our published article [1].

The statement authored by Zarir F. Udwadia should read as follows:

“ZUF has participated in trials for Cipla Pharmaceutical and Boehringer for Pirfenidone and Nintedanib, two of the drugs that were referred to in the article.”